Contrast enhanced ultrasound characterization of surgically resected renal masses in patients on dialysis

Diagnostic work-up of suspicious renal masses has traditionally been conducted with contrast-enhanced computed tomography (CECT) and/or magnetic resonance imaging (MRI). However, patients who are not candidates for intravenous contrast due to allergy, renal insufficiency, or those on dialysis are di...

Full description

Saved in:

Bibliographic Details
Published in:	Scandinavian journal of urology Vol. 53; no. 5; p. 344
Main Authors:	Kahn, Amanda E, Ostrowski, Andrew K, Caserta, Melanie P, Galler, Isabella J, Thiel, David D
Format:	Journal Article
Language:	English
Published:	England 03-09-2019
Subjects:	Aged Carcinoma, Renal Cell - complications Carcinoma, Renal Cell - diagnostic imaging Carcinoma, Renal Cell - surgery Contrast Media Humans Kidney Failure, Chronic - complications Kidney Failure, Chronic - therapy Kidney Neoplasms - complications Kidney Neoplasms - diagnostic imaging Kidney Neoplasms - surgery Male Middle Aged Renal Dialysis Retrospective Studies Sulfur Hexafluoride Ultrasonography - methods dialysis chronic renal insufficiency Renal cell carcinoma contrast-enhanced ultrasound imaging
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Diagnostic work-up of suspicious renal masses has traditionally been conducted with contrast-enhanced computed tomography (CECT) and/or magnetic resonance imaging (MRI). However, patients who are not candidates for intravenous contrast due to allergy, renal insufficiency, or those on dialysis are discouraged from utilizing traditional contrast imaging due to risks of anaphylaxis, nephrotoxicity, or further kidney damage. We evaluated contrast-enhanced ultrasound (CEUS) in patients on dialysis who would benefit from alternative imaging options to CECT or MRI. Following IRB approval, nine renal masses from eight patients (aged 54-74 years) with chronic renal insufficiency were evaluated with CEUS and shown to be enhancing after the intravenous administration of ultrasound contrast agent. The ultrasound contrast agent Lumason (Sulfur hexafluoride lipid type-A microspheres, Bracco Diagnostics, Monroe Township, NJ, USA) was utilized. Enhancement was considered present when microbubble contrast agent was visualized within the lesion of interest. Nine CEUS enhancing masses were pathologically examined following laparoscopic radical nephrectomy. Eight of the nine lesions were renal cell carcinoma (two clear cell, four papillary, two cystic). One resected mass was an unspecified benign renal lesion. In this sample of surgically resected tumors, CEUS was effective in characterizing renal lesions as solid neoplasms or complex cystic lesions suspicious for neoplasm-findings which merit further investigation.
ISSN:	2168-1813
DOI:	10.1080/21681805.2019.1666917